Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Predicting cancer risk in the long term

Every day, people make assumptions, educated and not, about their risk for developing cancer.

17 Apr 2007

BioForce Nanosciences pursues support for ViriChip platform

BioForce Nanosciences continues their effort to fund development of the ViriChip platform, a patented system designed to rapidly and nondestructively detect and identify whole viruses.

12 Apr 2007

Roche and Transgene S.A. partner on HPV vaccine program

Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.

11 Apr 2007

HPV scientists to be honored

The potential for a new vaccine to eliminate cervical cancer caused by the human papillomavirus, or HPV, will be celebrated during the James P. Wilmot Cancer Center's eighth annual Discovery Ball on Saturday, April 28, at the Rochester Riverside Convention Center.

11 Apr 2007

Experimental flu vaccine produced using insect cells shows promise

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.

11 Apr 2007

Montefiore Medical Center launches human papilloma virus clinic

The only HPV (Human Papilloma Virus) Vaccine Clinic of its kind has been launched at Montefiore Medical Center.

7 Apr 2007

Takeda acquires rights for drug to treat cervical dysplasia, HPV

Japanese pharmaceutical company Takeda on Friday announced that it has acquired from 3M the rights for a drug, called R-851, to treat cervical dysplasia and "high-risk" human papillomavirus infection, Reuters reports.

2 Apr 2007

New York progresses HPV vaccine distribution to health providers, school clinics

The New York City Department of Health and Mental Hygiene on Thursday announced that it has distributed 57,810 doses of Merck's human papillomavirus vaccine Gardasil to city health providers, including school-based health clinics, the New York Post reports.

2 Apr 2007

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

If licensed, the vaccine will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.

1 Apr 2007

HPV vaccine proposals in Florida, Georgia, North Carolina, South Dakota

Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

22 Mar 2007

Canada budgets $258 million for human papillomavirus vaccination programs

The Canadian government on Monday announced that it is including about $258 million in the 2007-2008 budget to help pay for provincial human papillomavirus vaccination programs, Toronto's Globe and Mail reports.

22 Mar 2007

AACR's Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller

Scientists whose discoveries have led to fundamental advances in the science and treatment of cancer are the recipients of two prestigious international prizes offered by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research.

22 Mar 2007

Lack of preventive care, not HPV vaccine, 'real' reason 'too many women still die of cervical cancer'

The "real" reason that "[t]oo many women still die of cervical cancer" is the "lack of access to preventive medical care for low-income women and not the lack of a vaccine," Wall Street Journal columnist and Illinois-based physician Benjamin Brewer writes in an opinion piece.

11 Mar 2007

Gardasil not provided at most New York City health clinics

Merck's human papillomavirus vaccine Gardasil is not provided at most New York City health clinics, and girls and women who are eligible for no-cost or low-cost vaccination often are told they must pay for it, according to a report released on Wednesday by Public Advocate Betsy Gotbaum, the New York Sun reports.

11 Mar 2007

Two Roche HPV diagnostic tests to receive FDA review

Roche on Tuesday announced that FDA will review applications for the company's two human papillomavirus diagnostic tests, the Baltimore Sun reports

8 Mar 2007

Debate over HPV vaccine 'clouded' by worries about promiscuity

The debate over the Merck's human papillomavirus vaccine Gardasil has been "clouded" by "worries about promiscuity," New York Times reporter Denise Grady writes in a column

8 Mar 2007

FDA accepts two Roche diagnostics HPV tests for review

Roche has announced today that the United States (U.S.) Food & Drug Administration has accepted for review its applications for two human papillomavirus (HPV) tests.

From Roche Sequencing and Life Science 6 Mar 2007

Debate over mandatory HPV vaccination

The Washington Post on Sunday examined the "widespread backlash" toward proposals to mandate human papillomavirus vaccination for school attendance after dozens of states "enthusiastic[ally] embraced" HPV vaccines.

5 Mar 2007

Safety of Merck's HPV vaccine Gardasil 'lost' in debate

The effectiveness and safety of Merck's human papillomavirus vaccine Gardasil has "been lost" because of Merck's lobbying campaign for mandating vaccination for school attendance, and the "real losers" might be "girls and women who need access" to the vaccine, Boston Globe columnist Ellen Goodman writes in an opinion piece .

5 Mar 2007

Actions taken on HPV vaccine proposals in Kentucky, Massachusetts, New Mexico, Ohio, South Dakota and Virginia

4 Mar 2007

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Predicting cancer risk in the long term

BioForce Nanosciences pursues support for ViriChip platform

Roche and Transgene S.A. partner on HPV vaccine program

HPV scientists to be honored

Experimental flu vaccine produced using insect cells shows promise

Montefiore Medical Center launches human papilloma virus clinic

Takeda acquires rights for drug to treat cervical dysplasia, HPV

New York progresses HPV vaccine distribution to health providers, school clinics

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

HPV vaccine proposals in Florida, Georgia, North Carolina, South Dakota

Canada budgets $258 million for human papillomavirus vaccination programs

AACR's Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller

Lack of preventive care, not HPV vaccine, 'real' reason 'too many women still die of cervical cancer'

Gardasil not provided at most New York City health clinics

Two Roche HPV diagnostic tests to receive FDA review

Debate over HPV vaccine 'clouded' by worries about promiscuity

FDA accepts two Roche diagnostics HPV tests for review

Debate over mandatory HPV vaccination

Safety of Merck's HPV vaccine Gardasil 'lost' in debate

Actions taken on HPV vaccine proposals in Kentucky, Massachusetts, New Mexico, Ohio, South Dakota and Virginia

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in